eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
7/2007
vol. 11
 
Share:
Share:
abstract:

Targeted therapy Part I. Signalling by tyrosine kinase receptors

Beata Wiczyńska
,
Janusz Rolski

Współczesna Onkologia (2007) vol. 11; 7 (331–336)
Online publish date: 2007/10/02
View full text Get citation
 
Cell signalling is tightly controlled for normal cell function. The signal transduction system comprises ligands (growth factors, cytokines, hormones), transmembrane receptors and cytoplasmic secondary messengers. The crucial effectors in signalling cascades include the Ras-Raf-MAP pathway, lipid kinase phosphoinositide-3-kinase (PI3K) pathway and protein kinase C pathway. Dysregulation of the three major signalling pathways can lead to the malignant phenotype of uncontrolled proliferation, metastasis, angiogenesis and inhibition of apoptosis.
keywords:

signal transduction pathways, receptor tyrosine kinases, non-receptor tyrosine kinases, signaling molecules (ligands)

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.